openPR Logo
Press release

Global Non-Opioid Pain Relief Device Market to Double by 2032: From US$ 5,444.8 Million in 2023 to US$ 11,440.6 Million, Growing at a CAGR of 8.6%

09-20-2024 11:34 AM CET | Health & Medicine

Press release from: Astute Analytica

Global Non-Opioid Pain Relief Device Market to Double by 2032:

The global ๐ง๐จ๐ง-๐จ๐ฉ๐ข๐จ๐ข๐ ๐ฉ๐š๐ข๐ง ๐ซ๐ž๐ฅ๐ข๐ž๐Ÿ ๐๐ž๐ฏ๐ข๐œ๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ is poised for substantial growth, with a projected market value of ๐”๐’$ ๐Ÿ๐Ÿ,๐Ÿ’๐Ÿ’๐ŸŽ.๐Ÿ” ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ, up from ๐”๐’$ ๐Ÿ“,๐Ÿ’๐Ÿ’๐Ÿ’.๐Ÿ– ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘. This significant expansion represents a promising compound annual growth rate (๐‚๐€๐†๐‘) ๐จ๐Ÿ ๐Ÿ–.๐Ÿ”% ๐จ๐ฏ๐ž๐ซ ๐ญ๐ก๐ž ๐Ÿ๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐ฉ๐ž๐ซ๐ข๐จ๐ ๐Ÿ๐ซ๐จ๐ฆ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ.

๐“๐ก๐ž ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ž๐ซ๐ž- https://www.astuteanalytica.com/request-sample/non-opioid-pain-relief-device-market

The rising prevalence of chronic pain conditions, coupled with growing awareness of the risks associated with opioid-based treatments, has spurred the demand for non-opioid pain relief solutions. As healthcare systems worldwide prioritize patient safety and non-addictive alternatives, non-opioid pain relief devices are emerging as a vital component in pain management strategies. These devices offer innovative, non-invasive methods to manage pain, thus addressing the opioid crisis by providing safer and effective alternatives for patients suffering from acute and chronic pain conditions.

Technological advancements in pain relief devices, including transcutaneous electrical nerve stimulation (TENS), ultrasound therapy, and wearable devices, are driving the market forward. The increasing adoption of these solutions across hospitals, clinics, and home care settings underscores the critical role these devices play in improving patient outcomes without the risks of addiction or side effects commonly associated with opioids.

The global market's growth is further bolstered by favorable regulatory policies and increased investment in research and development aimed at enhancing the efficacy of non-opioid pain relief devices. With continued innovation and an expanding patient base, the market is expected to thrive, offering patients and healthcare providers reliable, long-term solutions to manage pain.

๐…๐จ๐ซ ๐ฆ๐ž๐๐ข๐š ๐ข๐ง๐ช๐ฎ๐ข๐ซ๐ข๐ž๐ฌ, ๐ฉ๐ฅ๐ž๐š๐ฌ๐ž ๐œ๐จ๐ง๐ญ๐š๐œ๐ญ:- https://www.astuteanalytica.com/industry-report/non-opioid-pain-relief-device-market

๐“๐จ๐ฉ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐†๐ฅ๐จ๐›๐š๐ฅ ๐๐จ๐ง-๐Ž๐ฉ๐ข๐จ๐ข๐ ๐๐š๐ข๐ง ๐‘๐ž๐ฅ๐ข๐ž๐Ÿ ๐ƒ๐ž๐ฏ๐ข๐œ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ

โ€ข Abbott Laboratories
โ€ข Bayer AG
โ€ข Bioelectronics Corporation
โ€ข Boston Scientific Corporation
โ€ข Medtronic plc
โ€ข Koninklijke Philips N.V.
โ€ข Neurometrix Inc.
โ€ข Nuvectra Corporation
โ€ข Omron Corporation
โ€ข Stryker Corporation
โ€ข SPR Therapeutics, LLC
โ€ข Stimwave LLC
โ€ข Thermotek Inc.
โ€ข Zynex Medical
โ€ข Other Prominent Players

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ :

๐๐ฒ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง

โ€ข Neuromuscular
โ€ข Musculoskeletal
โ€ข Injuries
โ€ข Diabetic Neuropathy
โ€ข Others

๐๐ฒ ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ

โ€ข Electroanalgesia
o Implantable Device
o Non-Implantable Device
๏‚ง Traditional TENS
๏‚ง Wearable TENS
๏‚ง Others
โ€ข Radiofrequency Ablation
โ€ข Other Emerging Technologies

๐๐ฒ ๐„๐ง๐ ๐”๐ฌ๐ž๐ซ

โ€ข Pain Management Centers
โ€ข Hospitals
โ€ข Homecare

๐๐ฒ ๐‘๐ž๐ ๐ข๐จ๐ง

โ€ข North America
o The U.S.
o Canada
o Mexico
โ€ข Europe
o Western Europe
๏‚ง The UK
๏‚ง Germany
๏‚ง France
๏‚ง Italy
๏‚ง Spain
๏‚ง Rest of Western Europe
o Eastern Europe
๏‚ง Poland
๏‚ง Russia
๏‚ง Rest of Eastern Europe
โ€ข Asia Pacific
o China
o India
o Japan
o Australia & New Zealand
o South Korea
o ASEAN
o Rest of Asia Pacific
โ€ข Middle East & Africa
o Saudi Arabia
o South Africa
o UAE
o Rest of MEA
โ€ข South America
o Argentina
o Brazil
o Rest of South America

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‘๐ž๐ฉ๐จ๐ซ๐ญ@- https://www.astuteanalytica.com/request-sample/non-opioid-pain-relief-device-market

๐€๐›๐จ๐ฎ๐ญ ๐€๐ฌ๐ญ๐ฎ๐ญ๐ž ๐€๐ง๐š๐ฅ๐ฒ๐ญ๐ข๐œ๐š:

Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.

They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyse for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.

๐†๐ž๐ญ ๐ข๐ง ๐ญ๐จ๐ฎ๐œ๐ก ๐ฐ๐ข๐ญ๐ก ๐ฎ๐ฌ

๐๐ก๐จ๐ง๐ž ๐ง๐ฎ๐ฆ๐›๐ž๐ซ: +18884296757
๐„๐ฆ๐š๐ข๐ฅ: sales@astuteanalytica.com
๐•๐ข๐ฌ๐ข๐ญ ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž: https://www.astuteanalytica.com/
LinkedIn | Twitter | YouTube | Facebook

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Non-Opioid Pain Relief Device Market to Double by 2032: From US$ 5,444.8 Million in 2023 to US$ 11,440.6 Million, Growing at a CAGR of 8.6% here

News-ID: 3662126 • Views: โ€ฆ

More Releases from Astute Analytica

Gum grafting market is set to reach valuation of US$ 892.9 million by 2033 | Astute Analytica
Gum grafting market is set to reach valuation of US$ 892.9 million by 2033 | Ast โ€ฆ
Astute Analytica released an extensive market assessment report titled "Global Gum grafting market: Trends, Industry Competition Analysis, Revenue, and Forecast to 2033." This report offers a deep dive into the current landscape and future forecasts of this dynamic industry, providing valuable insights for stakeholders and industry participants. The report thoroughly investigates the present and future scenarios of the global Gum grafting market. It highlights key trends and emerging opportunities while addressingโ€ฆ
Hospitals infection therapeutics market is poised to reach US$ 14.7 billion by 2033 | Astute Analytica
Hospitals infection therapeutics market is poised to reach US$ 14.7 billion by 2 โ€ฆ
Astute Analytica released an extensive market assessment report titled "Global Hospital infection therapeutics market: Trends, Industry Competition Analysis, Revenue, and Forecast to 2033." This report offers a deep dive into the current landscape and future forecasts of this dynamic industry, providing valuable insights for stakeholders and industry participants. The report thoroughly investigates the present and future scenarios of the global Hospital infection therapeutics market. It highlights key trends and emerging opportunitiesโ€ฆ
Radiopharmaceuticals market is poised to attain valuation of US$ 13.4 billion by 2033 | Astute Analytica
Radiopharmaceuticals market is poised to attain valuation of US$ 13.4 billion by โ€ฆ
Astute Analytica released an extensive market assessment report titled "Global Radiopharmaceuticals market: Trends, Industry Competition Analysis, Revenue, and Forecast to 2033." This report offers a deep dive into the current landscape and future forecasts of this dynamic industry, providing valuable insights for stakeholders and industry participants. The report thoroughly investigates the present and future scenarios of the global Radiopharmaceuticals market. It highlights key trends and emerging opportunities while addressing challenges facedโ€ฆ
Hospital supplies market size is set to expand beyond US$ 125.56 billion by 2033 | Astute Analytica
Hospital supplies market size is set to expand beyond US$ 125.56 billion by 2033 โ€ฆ
Astute Analytica released an extensive market assessment report titled "Global Hospital supplies market: Trends, Industry Competition Analysis, Revenue, and Forecast to 2033." This report offers a deep dive into the current landscape and future forecasts of this dynamic industry, providing valuable insights for stakeholders and industry participants. The report thoroughly investigates the present and future scenarios of the global Hospital supplies market. It highlights key trends and emerging opportunities while addressingโ€ฆ

All 5 Releases


More Releases for Corporation

Endotherapy Devices Market Key Players: Hoya Corporation, Olympus Corporation, S โ€ฆ
A fresh report titled โ€œEndotherapy Devices Marketโ€ has been presented by KD market insights. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for Endotherapy Devices Market. The competition analysis is also a major part of the report. The global endotherapy devices market is projected to reachโ€ฆ
Digital Living Room Market 2017-2025 | Samsung Corporation, Sharp Corporation, B โ€ฆ
Global Digital Living Room Market: Snapshot The living room gadgets in the early 1980s were predominantly televisions. Today, living rooms have evolved into a place with a number of devices thanks to inventions and evolution of the consumer electronics industry. Following this, researchers are focused on bridging the gaps between different devices in the living room by means of connected living rooms. This involves connecting the array of primary and secondaryโ€ฆ
Global Healthcare Clinical Analytics Market to 2022| IBM Corporation, Cerner Cor โ€ฆ
Albany, NY, 3rd December : Recent research and the current scenario as well as future market potential of "Global Market Study on Healthcare Clinical Analytics: North America to be the Most Lucrative Market During the Assessment Period (2017 - 2022)" globally. Introduction Persistence Market Research delivers yet another unbiased, comprehensive and insightful report titled โ€˜Healthcare Clinical Analytics Market: Global Industry Analysis (2012-2016) and Forecast (2017-2022)โ€™. Get PDF for more Professional and Technical insightsโ€ฆ
Endotherapy Devices Market Key Players : Hoya Corporation, Olympus Corporation, โ€ฆ
Endoscopy Devices Market is performed to examine abdominal pain, ulcers, digestive tract bleeding, and abnormal growths in the colon and other abdominal & gastrointestinal (GI) conditions. The minimally invasiveness of this procedure with fewer post operation complications makes it one of the most preferred and sought-after procedures in diagnostics and surgeries. The global endotherapy devices market is projected reach $5,015 million by 2024 from $3,369.0 million in 2017, growing atโ€ฆ
Endoscopy Devices Market Share with Olympus Corporation, HOYA Corporation, Fujif โ€ฆ
Endoscopy Devices Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $40,854 million by 2022 from $27,273 million in 2015, registering a CAGR of 5.7% during the period 2016 to 2022. The flexible endoscopes are expected to dominate the global endoscopy devices market. North America is projected to continue its lead, accounting for more than one-third share of the global endoscopy devices marketโ€ฆ
Digital Living Room Market 2017 - 2025 : Sharp Corporation, BenQ Corporation, So โ€ฆ
Global Digital Living Room Market: Snapshot The living room gadgets in the early 1980s were predominantly televisions. Today, living rooms have evolved into a place with a number of devices thanks to inventions and evolution of the consumer electronics industry. Following this, researchers are focused on bridging the gaps between different devices in the living room by means of connected living rooms. This involves connecting the array of primary and secondaryโ€ฆ